Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Index levels shift due to earnings, valuations, and macro surprises. Knowing the main drivers helps you anticipate potential reversals.
17,383 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
U.S. gasoline prices climbed to their highest level since 2023 as the Iran war stretches oil markets. AAA pegged the ...
Before you invest in a stock, ask three essential questions. This guide offers a practical framework to assess busine...
Microsoft is staring down a tough start to the year. Is the slide a red flag or a rare chance to buy a tech titan wit...
Bitcoin gains momentum, rising about 6% over the past week and briefly topping $83,000 before pulling back. Traders a...
SUI surged 37% over the past seven days, powered by institutional staking inflows and a protocol upgrade that enables...
XRP has spent 2026 stuck between $1.30 and $1.50, with repeated tests at the ceiling and a steady floor around $1.38....
Ripple vaults onto CNBC’s disruptor list, while XRP trades in a tight range. The token hovered around $1.35 as market...
Ripple-focused ETFs posted another week of net inflows even as XRP struggled to rally. The divergence highlights a sp...
The bitcoin’s drop toward $72,000 intensified as U.S.-Iran tensions resurfaced, prompting a risk-off move across cryp...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
Top U.S. real estate teams and agents posted higher sales volume in 2025, according to RealTrends Verified 2026. The ...